Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) - Global Forecast to 2018

等温核酸増幅技術(INAAT)のグローバル市場(~2018)

◆タイトル:Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) - Global Forecast to 2018
◆商品コード:Markets-BT-2491
◆調査・発行会社:MarketsandMarkets
◆発行日:2014年5月
◆ページ数:215
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single userUSD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User(~5名)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate licence (社内共有可) USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"等温核酸増幅技術(INAAT)のグローバル市場(~2018)"について調査・分析し、イントロダクション、エグゼクティブサマリー、市場の成長要因、阻害要因、バリューチェーン分析、投資機会、市場の動態、技術別分析、製品別分析、用途別分析、需要先別分析、地域別分析、市場規模及び予測、競争状況、新製品発売、主要企業(ベンダー)分析等の情報をお届けいたします。

The isothermal nucleic acid amplification technology (INAAT) market is poised to reach $1,651 million by 2018 at a CAGR of 13.5% during the forecast period. Though PCR technology dominates the nucleic acid amplification technology market currently, adoption of INAAT technology is expected to be significant in coming years as it offers better clinical results in detecting pathogens during point-of-care testing.
Amongst different products, reagent segment is expected to grow at a faster growth due to its increasing demand in reliable, specific and faster detection of chronic diseases and genetic disorders. On the other hand, infectious disease was found to be the highest revenue generating application segment of isothermal nucleic acid amplification technology (INAAT) market in 2013; it is also expected to grow at higher CAGR of 14.4% during the forecast period due to increasing prevalence of various infectious diseases such as HIV and hepatitis A & B and increasing adoption of INAAT in advanced detection of pathogens globally. Amongst different end-users, adoption of INAAT technologies in reference laboratories is expected to be significant due to increasing importance of advanced technologies in different complex molecular testing.
North America commanded the largest market share of about 44% in 2013; whereas, Asian INAAT market is expected to witness the highest CAGR. High prevalence rate of infectious diseases and significant adoption of novel technologies are the major driving factors in the Asian INAAT market. Leading players in the global INAAT market are also expected to address the unmet needs in emerging nations such as India, China, South Africa, Singapore, and Middle East among others.
The grey area, while estimating the market size, includes the overlapping nature of the applications. The application segment included infectious diseases, blood screening, genetics, oncology, research. It was difficult to evaluate the appropriate applications of INAAT; these were later clarified with the help of various experts that participated during the study. Technology market is not estimated as these are proprietary technologies of leading companies. However, qualitative information such as technology evolution, value chain analysis, comparative analysis of various proprietary technologies, and technology roadmap are incorporated in the research study.
The notable players in the global isothermal nucleic acid amplification technology market include Alere, Inc. (U.S.), Becton, Dickinson & Company (U.S.), BioHelix (U.S.), bioMerieux (France), Hologic Gene-Probe (U.S.), and QIAGEN (The Netherlands).
The extensive market study covers a detailed coverage of market momentum, an in-depth analysis of various influencing factors as well as a comprehensive snapshot of competitive landscape. Such all-inclusive research would help market players to identify growth potential of different sub-segments and formulate a suitable strategy to enter various related industries with the best portfolio.

【レポートの目次】

Table Of Content

1 Introduction
1.1 Objectives Of The Study
1.2 Report Scope
1.3 Research Methodology
1.4 Key Data From Secondary & Primary Sources

2 Executive Summary

3 Technology Landscape Analysis
3.1 Technology Overview
3.2 INAAT Vs. Conventional Methods – Competitive Advantages
3.3 Technology Value Chain Analysis
3.4 Technology Capability and Maturity
3.5 Test Results General Nat Vs. INAAT Poct
3.6 Comparative Analysis Of INAAT Types

4 Technology Investment Potential
4.1 Investment Climate Assessment
4.1.1 Investor Network
4.1.1.1 Investment Climate Assessment
4.1.1.2 Philanthropic Bodies
4.1.1.3 Private Investors & Venture Capital Firms
4.1.1.4 Insights on Current and Future Technology Investment Trends
4.1.1.5 Some Of The Funds and Investments on INAAT
4.2 Evaluation Of Technologies Available For Licensing & Acquisition For Stakeholders
4.3 Analysis Of Potential Application Areas For Technology Investment Using Ose Grid
4.3.1 Ose – Parameters For Evaluation

5 Market Landscape Analysis
5.1 Market Segmentation
5.2 Market Share in Molecular Diagnostics (Mdx)
5.3 Market Dynamics
5.3.1 Drivers – Description
5.3.2 Restraints – Description
5.3.3 Challenges – Description
5.4 Demand-Side Analysis

6 Product Market
6.1 Product/Technology Innovations – Applications
6.1.1 Product/Technology Innovations – Applications
6.1.1.1 INAAT Instrument Market – By Geography
6.1.1.2 INAAT Reagent Market – By Geography

7 Applications Market
7.1 INAAT & Molecular Diagnostics
7.2 Infectious Disease Diagnostics
7.3 Blood Screening
7.4 Laboratory Research
7.5 Cancer Research
7.6 Global INAAT Market – By Application (2013–2018)
7.6.1 INAAT Infectious Diseases Market, By Geography
7.6.2 INAAT Blood Screening Market – By Geography
7.6.3 INAAT Research Market – By Geography

8 End-User Market
8.1 Global Isothermal Nucleic Acid Amplification Technology Market – By End User (2013–2018)
8.2 Global Market – By End User
8.2.1 INAAT Hospitals Market – By Geography
8.2.2 INAAT Reference Laboratories Market – By Geography
8.2.3 INAAT Other End-Users Market – By Geography
8.3 INAAT Market For Hospitals, By Application
8.4 INAAT Market For Reference Laboratories, By Application
8.5 INAAT Market For Other End Users, By Application

9 Geographic Analysis
9.1 Technology Adoption & Development – Key Findings
9.1.1 Global Isothermal Nucleic Acid Amplification Technology Market – By Geography (2013–2018)
9.2 North America
9.2.1 North America – INAAT Market, By Application
9.2.2 North America – Market, By Product
9.2.3 North America – Market, By End User
9.3 Europe
9.3.1 Europe – INAAT Market, By Application
9.3.2 Europe – Market, By Product
9.3.3 Europe – Market, By End User
9.4 Asia
9.4.1 Asia – INAAT Market, By Application
9.4.2 Asia – Market, By Product
9.4.3 Asia – Market, By End User
9.5 Rest Of The World (ROW)
9.5.1 ROW– INAAT Market, By Application
9.5.2 ROW– Market, By Product
9.5.3 ROW– Market, By End User
9.6 Regions With High Technology Adoption

10 Competitive Landscape
10.1 Partnerships, Collaborations & Agreements
10.2 New Product Launches
10.3 Mergers and Acquisitions

11 Company Profiles
11.1 Alere
11.2 Becton, Dickinson and Company (Bd)
11.3 Biohelix
11.4 Biomerieux
11.5 Eiken Chemical Co., Ltd.
11.6 Hologic Gen-Probe
11.7 Lucigen
11.8 Meridian Bioscience, Inc.
11.9 New England Biolabs
11.10 Novartis Diagnostics
11.11 Nugen
11.12 Qiagen
11.13 Ustar Biotechnologies (Hangzhou) Ltd.

List Of Tables (31)

Table 1 NIH Funding Details and Estimation For Infectious Diseases During The Fiscal Year (Fy) 2010–2015
Table 2 Gates Foundation Grants ($) (2010-2014)
Table 3 Global Isothermal Nucleic Acid Amplification Technology Market, By Product, 2011–2018 ($Million)
Table 4 INAAT Instruments Market, By Geography, 2011–2018 ($Million)
Table 5 INAAT Reagents Market, By Geography, 2011–2018 ($Million)
Table 6 Global Isothermal Nucleic Acid Amplification Technology Market, By Application, 2011–2018 ($Million)
Table 7 INAAT Infectious Diseases Market, By Geography, 2011–2018 ($Million)
Table 8 INAAT Blood Screening Market, By Geography, 2011–2018 ($Million)
Table 9 INAAT Research Market, By Geography, 2011–2018 ($Million)
Table 10 Global Isothermal Nucleic Acid Amplification Technology Market, By End User, 2011–2018 ($Million)
Table 11 INAAT Hospitals Market, By Geography, 2011–2018 ($Million)
Table 12 INAAT Reference Laboratories Market, By Geography, 2011–2018 ($Million)
Table 13 INAAT Other End-Users Market, By Geography, 2011–2018 ($Million)
Table 14 INAAT Hospital Market Revenue, By Application, 2011–2018 ($Million)
Table 15 INAAT Reference Laboratories Market Revenue, By Application, 2011–2018 ($Million)
Table 16 INAAT Other End Users Market Revenue, By Application, 2011–2018 ($Million)
Table 17 North America: Market, By Application, 2011–2018 ($Million)
Table 18 North America: Market, By Product, 2011–2018 ($Million)
Table 19 North America: Market, By End User, 2011–2018 ($Million)
Table 20 Europe: Market, By Application, 2011–2018 ($Million)
Table 21 Europe: Market, By Product, 2011–2018 ($Million)
Table 22 Europe: Market, By End User, 2011–2018 ($Million)
Table 23 Asia: Market, By Application, 2011–2018 ($Million)
Table 24 Asia: Market, By Product, 2011–2018 ($Million)
Table 25 Asia: Market, By End User, 2011-2018 ($Million)
Table 26 ROW: Market, By Application, 2011-2018 ($Million)
Table 27 ROW: Market, By Product, 2011-2018 ($Million)
Table 28 ROW: Market, By End User, 2011-2018 ($Million)
Table 29 Partnerships, Collaborations & Agreements, 2011–2014
Table 30 New Product Launches, 2011–2014
Table 31 Mergers & Acquisitions, 2011–2014

List Of Figures (53)

Figure 1 Research Methodology
Figure 2 INAAT Vs. Molecular Diagnostics: Market Revenue Forecast, 2011–2018
Figure 3 Technology Evolution
Figure 4 INAAT Vs. Conventional Methods – Competitive Advantages
Figure 5 Technology Value Chain Analysis
Figure 6 INAAT Capability Towards Poct
Figure 7 Test Results General Nat Vs. INAAT Poct
Figure 8 Comparative Analysis Of INAAT Types
Figure 9 Technology Roadmap
Figure 10 Attractive Forces For Increased Market Value
Figure 11 Investor Network
Figure 12 NIH Funds Towards Infectious Diseases
Figure 13 Opportunity Strategic Evaluation Analysis
Figure 14 Market Segmentation
Figure 15 Market Share in Molecular Diagnostics (Mdx)
Figure 16 Market Dynamics
Figure 17 Drivers Impact – Timeline
Figure 18 Restraints Impact – Timeline
Figure 19 Current and Emerging Opportunities
Figure 20 Demand-Side Analysis
Figure 21 Market Share, By Product, 2013–2018
Figure 22 Global Market, By Product, 2013 & 2018 ($Million)
Figure 23 INAAT Instruments Market, By Geography, 2013 & 2018 ($Million)
Figure 24 Global INAAT Reagents Market, By Geography, 2013 & 2018 ($Million)
Figure 25 Isothermal Nucleic Acid Amplification Technology Applications Market
Figure 26 INAAT Products Currently Available For Infectious Diseases
Figure 27 Market Share, By Application, 2013–2018
Figure 28 Global Market, By Application, 2013 & 2018 ($Million)
Figure 29 INAAT Infectious Diseases Market, By Geography, 2013 & 2018 ($Million)
Figure 30 INAAT Blood Screening Market, By Geography, 2013 & 2018 ($Million)
Figure 31 INAAT Research Market, By Geography, 2013 & 2018 ($Million)
Figure 32 Market Share, By End User, 2013–2018
Figure 33 Global Market, By End-User, 2013 & 2018 ($Million)
Figure 34 INAAT Hospitals Market, By Geography, 2013 & 2018 ($Million)
Figure 35 INAAT Reference Laboratories Market, By Geography, 2013 & 2018 ($Million)
Figure 36 INAAT Other End-Users Market, By Geography, 2013 & 2018 ($Million)
Figure 37 INAAT Hospital Market Revenue, By Application, 2013 Vs. 2018, ($Million)
Figure 38 INAAT Reference Laboratories Market Revenue, By Application, 2013 Vs 2018 ($Million)
Figure 39 INAAT Others End Users Market Revenue, By Application, 2013 Vs. 2018 ($Million)
Figure 40 Market Share, By Geography, 2013–2018
Figure 41 North America: Market, By Application, 2013 Vs. 2018 ($Million)
Figure 42 North America: Market, By Product, 2013 Vs.2018 ($Million)
Figure 43 North America: Market, By End User, 2013 Vs. 2018 ($Million)
Figure 44 Europe: Market, By Application, 2013 Vs.2018 ($Million)
Figure 45 Europe: Market, By Product, 2013 Vs.2018 ($Million)
Figure 46 Europe: Market, By End User, 2013 Vs.2018 ($Million)
Figure 47 Asia: Market, By Application, 2013 Vs.2018 ($Million)
Figure 48 Asia: Market, By Product, 2013 Vs.2018 ($Million)
Figure 49 Asia: Market, By End User, 2013 Vs.2018 ($Million)
Figure 50 ROW: Market, By Application, 2013 Vs.2018 ($Million)
Figure 51 ROW: Market, By Product, 2013 Vs.2018 ($Million)
Figure 52 ROW: Market, By End User, 2013 Vs.2018 ($Million)
Figure 53 Key Growth Strategies Of The Global Isothermal Nucleic Acid Amplification Technologies Market, 2011–2014

【レポートのキーワード】

等温核酸増幅技術(INAAT)

★調査レポート[等温核酸増幅技術(INAAT)のグローバル市場(~2018)] ( Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) - Global Forecast to 2018 / Markets-BT-2491) 販売に関する免責事項
[等温核酸増幅技術(INAAT)のグローバル市場(~2018)] ( Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) - Global Forecast to 2018 / Markets-BT-2491) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆